Cargando…
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624615/ https://www.ncbi.nlm.nih.gov/pubmed/37679502 http://dx.doi.org/10.1038/s41375-023-02016-6 |
| _version_ | 1785130952886845440 |
|---|---|
| author | Eckardt, Jan-Niklas Bill, Marius Rausch, Christian Metzeler, Klaus Spiekermann, Karsten Stasik, Sebastian Sauer, Tim Scholl, Sebastian Hochhaus, Andreas Crysandt, Martina Brümmendorf, Tim H. Krug, Utz Wörmann, Bernhard Hiddemann, Wolfgang Görlich, Dennis Sauerland, Cristina Steffen, Björn Einsele, Hermann Neubauer, Andreas Burchert, Andreas Schäfer-Eckart, Kerstin Berdel, Wolfgang E. Schliemann, Christoph Krause, Stefan W. Hänel, Mathias Hanoun, Maher Kaufmann, Martin Fransecky, Lars Braess, Jan Ruhnke, Leo Schetelig, Johannes Middeke, Jan Moritz Serve, Hubert Baldus, Claudia D. Platzbecker, Uwe Müller-Tidow, Carsten Bornhäuser, Martin Herold, Tobias Thiede, Christian Röllig, Christoph |
| author_facet | Eckardt, Jan-Niklas Bill, Marius Rausch, Christian Metzeler, Klaus Spiekermann, Karsten Stasik, Sebastian Sauer, Tim Scholl, Sebastian Hochhaus, Andreas Crysandt, Martina Brümmendorf, Tim H. Krug, Utz Wörmann, Bernhard Hiddemann, Wolfgang Görlich, Dennis Sauerland, Cristina Steffen, Björn Einsele, Hermann Neubauer, Andreas Burchert, Andreas Schäfer-Eckart, Kerstin Berdel, Wolfgang E. Schliemann, Christoph Krause, Stefan W. Hänel, Mathias Hanoun, Maher Kaufmann, Martin Fransecky, Lars Braess, Jan Ruhnke, Leo Schetelig, Johannes Middeke, Jan Moritz Serve, Hubert Baldus, Claudia D. Platzbecker, Uwe Müller-Tidow, Carsten Bornhäuser, Martin Herold, Tobias Thiede, Christian Röllig, Christoph |
| author_sort | Eckardt, Jan-Niklas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10624615 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106246152023-11-05 Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification Eckardt, Jan-Niklas Bill, Marius Rausch, Christian Metzeler, Klaus Spiekermann, Karsten Stasik, Sebastian Sauer, Tim Scholl, Sebastian Hochhaus, Andreas Crysandt, Martina Brümmendorf, Tim H. Krug, Utz Wörmann, Bernhard Hiddemann, Wolfgang Görlich, Dennis Sauerland, Cristina Steffen, Björn Einsele, Hermann Neubauer, Andreas Burchert, Andreas Schäfer-Eckart, Kerstin Berdel, Wolfgang E. Schliemann, Christoph Krause, Stefan W. Hänel, Mathias Hanoun, Maher Kaufmann, Martin Fransecky, Lars Braess, Jan Ruhnke, Leo Schetelig, Johannes Middeke, Jan Moritz Serve, Hubert Baldus, Claudia D. Platzbecker, Uwe Müller-Tidow, Carsten Bornhäuser, Martin Herold, Tobias Thiede, Christian Röllig, Christoph Leukemia Letter Nature Publishing Group UK 2023-09-07 2023 /pmc/articles/PMC10624615/ /pubmed/37679502 http://dx.doi.org/10.1038/s41375-023-02016-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Eckardt, Jan-Niklas Bill, Marius Rausch, Christian Metzeler, Klaus Spiekermann, Karsten Stasik, Sebastian Sauer, Tim Scholl, Sebastian Hochhaus, Andreas Crysandt, Martina Brümmendorf, Tim H. Krug, Utz Wörmann, Bernhard Hiddemann, Wolfgang Görlich, Dennis Sauerland, Cristina Steffen, Björn Einsele, Hermann Neubauer, Andreas Burchert, Andreas Schäfer-Eckart, Kerstin Berdel, Wolfgang E. Schliemann, Christoph Krause, Stefan W. Hänel, Mathias Hanoun, Maher Kaufmann, Martin Fransecky, Lars Braess, Jan Ruhnke, Leo Schetelig, Johannes Middeke, Jan Moritz Serve, Hubert Baldus, Claudia D. Platzbecker, Uwe Müller-Tidow, Carsten Bornhäuser, Martin Herold, Tobias Thiede, Christian Röllig, Christoph Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification |
| title | Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification |
| title_full | Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification |
| title_fullStr | Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification |
| title_full_unstemmed | Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification |
| title_short | Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification |
| title_sort | secondary-type mutations do not impact outcome in npm1-mutated acute myeloid leukemia – implications for the european leukemianet risk classification |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624615/ https://www.ncbi.nlm.nih.gov/pubmed/37679502 http://dx.doi.org/10.1038/s41375-023-02016-6 |
| work_keys_str_mv | AT eckardtjanniklas secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT billmarius secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT rauschchristian secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT metzelerklaus secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT spiekermannkarsten secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT stasiksebastian secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT sauertim secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT schollsebastian secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT hochhausandreas secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT crysandtmartina secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT brummendorftimh secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT krugutz secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT wormannbernhard secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT hiddemannwolfgang secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT gorlichdennis secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT sauerlandcristina secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT steffenbjorn secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT einselehermann secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT neubauerandreas secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT burchertandreas secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT schafereckartkerstin secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT berdelwolfgange secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT schliemannchristoph secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT krausestefanw secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT hanelmathias secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT hanounmaher secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT kaufmannmartin secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT franseckylars secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT braessjan secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT ruhnkeleo secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT scheteligjohannes secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT middekejanmoritz secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT servehubert secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT baldusclaudiad secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT platzbeckeruwe secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT mullertidowcarsten secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT bornhausermartin secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT heroldtobias secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT thiedechristian secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification AT rolligchristoph secondarytypemutationsdonotimpactoutcomeinnpm1mutatedacutemyeloidleukemiaimplicationsfortheeuropeanleukemianetriskclassification |